Pin your most used calculators here by clicking the star in the dropdown.
Moore Criteria (Advanced Cervical)
Clinical Context & Background
The Moore Criteria identify poor prognostic factors in patients with stage IVB, recurrent, or persistent cervical cancer treated with cisplatin-based chemotherapy. The score predicts response rate and overall survival.
Formula Logic
Sum of 5 risk factors: Black race, PS > 0, Pelvic disease, Prior Cisplatin, DFI < 1 yr.Reference Data
| Risk Group | Risk Factors | Median Survival |
|---|---|---|
| Low Risk | 0 - 1 | 13 months |
| Intermediate Risk | 2 - 3 | 8 months |
| High Risk | 4 - 5 | 5 months |
Evidence-based oncology decision support. Verify with clinical guidelines.